(2022). Podotimod in pediatric recurrent respiratory tract infections: A cost-utility analysis.
Chicago Style (17th ed.) CitationPodotimod in Pediatric Recurrent Respiratory Tract Infections: A Cost-utility Analysis. 2022.
MLA (8th ed.) CitationPodotimod in Pediatric Recurrent Respiratory Tract Infections: A Cost-utility Analysis. 2022.
Warning: These citations may not always be 100% accurate.
